本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sagimet Biosciences Inc.

6.19
+0.12001.98%
盘后6.190.00000.00%16:33 EDT
成交量:28.86万
成交额:176.56万
市值:2.01亿
市盈率:-3.92
高:6.27
开:6.05
低:5.89
收:6.07
52周最高:11.41
52周最低:2.02
股本:3,252.16万
流通股本:2,262.65万
量比:0.73
换手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-1.5800
每股收益(LYR):-1.5800
净资产收益率:-38.20%
总资产收益率:-25.70%
市净率:1.81
市盈率(LYR):-3.92

数据加载中...

2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/13

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

重要事件披露

Form 8-K - Current report
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/24

重要事件披露

Form 8-K - Current report
2024/01/24

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/24

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933